Welltower Inc. Stock News

Welltower's (WELL) diversified portfolio of healthcare assets, strategic repositioning efforts and strong balance sheet bode well. Stiff competition and rising interest rates are key concerns.

Jonathan Peterson, Jefferies managing director, joins 'Power Lunch' to discuss Peterson's thoughts on real estate investment trusts, the subtypes within the hospital sector and more.

Welltower has had a rough patch with the pandemic hurting profitability of its operators. The most recent big news is a new JV on its ProMedica assets.

Welltower (WELL) reported earnings 30 days ago. What's next for the stock?

We look for areas in which fundamentals and pricing do not match up. Subsectors are significantly mispriced right now.

The company reported encouraging quarterly results and announced a fresh new deal.

Welltower Inc. (NYSE:WELL ) Q3 2022 Earnings Conference Call November 8, 2022 9:00 AM ET Company Participants Matt McQueen - General Counsel Shankh Mitra - CEO John Burkart - COO Tim McHugh - CFO Nikh

Welltower (WELL) reports healthy Q3 results, with the top line growing year over year. The SHO portfolio witnesses improvement in occupancy.

Welltower (WELL) delivered FFO and revenue surprises of 0% and 1.11%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Positive operating trends in the SHO portfolio are likely to have aided Welltower's (WELL) Q3 earnings. However, a delay in the disbursements of HHS funds and interest rate hikes might have been deter

Healthcare REITs have lagged over the past quarter as sharply higher labor costs, a sluggish post-COVID recovery in patient volumes, and the waning of government fiscal support have pressured operator

Brian Jones, Neuberger Berman portfolio manager, joins 'The Exchange' to discuss opportunity finds in REITs.

Despite a healthy occupancy trend in the seniors housing operating (SHO) portfolio, Welltower (WELL) is likely to experience Q3 FFO below the midpoint of its guidance due to delayed HHS funds.

Welltower's stock price is now trading materially below its recent highs. It's seeing a strong rebound in its senior housing segment, with revenue outpacing expense growth.

Rise in healthcare expenditure by an aging population and strategic acquisitions are likely to aid Welltower (WELL). Stiff competition and earnings dilution in the near term from asset sales are woes.